CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Conditions:   Non-hodgkin Lymphoma;   Acute Lymphoblastic Leukemia Interventions:   Biological: CD19.CAR-multiVST for Group A;   Biological: CD19.CAR-multiVST for Group B Sponsors:   Baylor College of Medicine;   Texas Children's Hospital;   The Methodist Hospital System;   Center for Cell and Gene Therapy, Baylor College of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials